Effective management of advanced urothelial bladder cancer is challenging. New
discoveries that improve our understanding of molecular bladder cancer subtypes have …

Purpose To review the currently available literature reporting the patterns of recurrence and
their predictive factors after open radical cystectomy (RC) for bladder cancer. Methods A …

Purpose To compare perioperative outcomes and complications of extracorporeal (ECUD)
vs intracorporeal urinary diversion (ICUD) in patients after undergoing robot-assisted radical …

Background Uptake of perioperative chemotherapy for muscle-invasive bladder cancer
(MIBC) has been historically poor. We describe contemporary use of neoadjuvant (NACT) …

Purpose: Poor preoperative nutritional status is associated with a higher complication rate
after radical cystectomy in patients with bladder cancer. Given the short interval between …

Background Approximately half of patients who undergo radical cystectomy (RC) for muscle-
invasive bladder cancer (MIBC) will succumb to metastatic disease. We summarize the …

Urothelial carcinoma (UC) of the bladder and upper urinary tract still results an open
challenge for clinical oncologists. Excluding selected patients who will particularly benefit …

Purpose To evaluate the accuracy of the American College of Surgeons National Surgical
Quality Improvement Programs (ACS-NSQIP) surgical risk calculator in patients undergoing …

Background Cisplatin-based neoadjuvant chemotherapy (NAC) before radical cystectomy is
the standard of care in muscle-invasive bladder cancer. There are limited data regarding …

The use of immunotherapy has revolutionized the management of patients with locally
advanced, unresectable, and metastatic urothelial carcinoma (UC); however, platinum …